Rep. Frank Pallone, Jr., is seeking information from six IDR entities amid concerns about No Surprises Act arbitration ...

Flare Capital Partners led the Series A round. Craft, Obvious Ventures, Eniac Ventures, InHealth Ventures, Epsilon Health ...

Forus' $150 million Series C round was led by Bain Capital Ventures, with participation from Thrive Capital, General Catalyst ...

A roundup of the seven most notable hospital mergers and acquisitions announced or completed this summer, including Prisma Health’s acquisition of Erlanger Health and Sanford Health’s purchase of Nort ...

In a mid-stage study, Teva’s drug prevented intestinal damage in celiac disease patients who underwent a gluten challenge — ...

Nutromics earned FDA breakthrough device designation for its wearable patch that tracks vancomycin levels in real time. The ...

A new report found that while more than 90% of health systems have deployed third-party AI tools, less than half have the ...

GSK’s messenger RNA vaccine for seasonal influenza is designed to prompt an immune response to two proteins on the surface of ...

The 2026 Healthcare AI Readiness Index, a new report by Cotiviti and MedCity News, is based on a survey of 70 healthcare leaders over the summer and shares candid views of how they balance harnessing ...

Takeda Pharmaceutical’s Mimrylo is now approved for treating polycythemia vera, a rare blood cancer with limited therapeutic ...

The neurological deterioration and progressive muscle weakness caused by Alexander disease now have their first FDA-approved therapy, a genetic medicine that Ionis Pharmaceuticals designed to address ...

Judi Health expanded its healthcare network to offer specialized virtual care for cancer, autoimmune and GI conditions while ...